Powerful new approaches and advances in medical systems drive increasingly high expectations for healthcare providers internationally. The form of digital healthcare – a suite of new technologies offering significant benefits in cost and quality – allow institutions to keep pace with society’s needs. This book covers the need for responsible innovation in this area, exploring the issues of implementation as well as potential negative consequences to ensure digital healthcare delivers for the benefit of all stakeholders.
Browse by title
The Case of Independent Living
Steven DeMello and Peder Inge Furseth
There is a growing trend toward the integration of public and private entities in the delivery of public services. This book aims to improve the ability to innovate successfully in large-scale public/private endeavors. The authors develop an underpinning theory of innovation, and extend it to address key issues in public/private collaboration. As an example, they explore the subject of independent living for seniors and disabled people across four countries – the US, UK, Norway and Japan. The resulting model provides a vehicle for all major stakeholders to better understand the dynamics of innovation, which will in turn offer the opportunity to improve performance and successful adoption.
Theory, Methodology and Applications
Innovation and Health investigates both the origin and the diffusion of novelty in the field of health. It also provides a critical discussion of the methodology and theory of health economics. Neoclassical and evolutionary elements are combined to produce a comprehensive view of the commodity of ‘health’ beyond a pure ‘market’ perspective. Thus, the intangible dimension of health is taken into account. The methodological framework developed serves as a basis for several theoretical and empirical applications such as the creation of medical knowledge, the evolution of networks and the process of invention, innovation and diffusion in the health care sector.
Creating and Capturing Value
This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book.